CCN3 and neoplasm: Blocking various chemokines produced by tumor and stromal cells, such as monocyte chemoattractant protein-1 (MCP-1), prostaglandin E2 (PGE2), colony-stimulating factor 1, and CCN3, can inhibit the recruitment of TAMs to tumor sites, thereby suppressing tumor progression and preventing metastasis (127, 128).